Sabella Lauren M.'s most recent trade in Mannkind Corp was a trade of 16,407 Common Stock, $.01 Par Value done at an average price of $5.1 . Disclosure was reported to the exchange on March 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mannkind Corp | Lauren M. Sabella | EVP Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.10 per share. | 27 Mar 2025 | 16,407 | 357,849 (0%) | 0% | 5.1 | 83,676 | Common Stock, $.01 Par Value |
| Mannkind Corp | Lauren M. Sabella | EVP Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.83 per share. | 15 Jul 2024 | 1,817 | 374,256 (0%) | 0% | 5.8 | 10,593 | Common Stock, $0.01 Par Value |
| Mannkind Corp | Lauren M. Sabella | EVP Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 3.09 per share. | 15 Jul 2024 | 722 | 376,073 (0%) | 0% | 3.1 | 2,231 | Common Stock, $0.01 Par Value |
| Mannkind Corp | Lauren M. Sabella | EVP Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 158,000 | 158,000 | - | - | Performance Restricted Stock Unit | |
| Mannkind Corp | Lauren M. Sabella | EVP Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 129,000 | 375,351 (0%) | 0% | 0 | Common Stock, $.01 Par Value | |
| Mannkind Corp | Sabella Lauren M. | EVP Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 3.27 per share. | 31 Dec 2023 | 15,290 | 263,435 (0%) | 0% | 3.3 | 49,998 | Common Stock, $0.01 Par Value |
| Mannkind Corp | Sabella Lauren M. | EVP Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 3.09 per share. | 31 Dec 2023 | 711 | 248,145 (0%) | 0% | 3.1 | 2,197 | Common Stock, $0.01 Par Value |
| Mannkind Corp | Lauren M. Sabella | EVP Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 28,000 | 28,000 | - | - | Performance Restricted Stock Unit | |
| Mannkind Corp | Lauren M. Sabella | EVP Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 23,250 | 247,434 (0%) | 0% | 0 | Common Stock, $.01 Par Value | |
| Mannkind Corp | Lauren M. Sabella | EVP Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2023 | 210,000 | 224,184 | - | 0 | Restricted Stock Unit | |
| Mannkind Corp | Lauren M. Sabella | EVP Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 4.23 per share. | 15 May 2023 | 14,184 | 14,184 (0%) | 0% | 4.2 | 59,998 | Common Stock,$.01 par value |
| Acorda Therapeutics Inc | Lauren M. Sabella | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.40 per share. | 03 Sep 2022 | 1,511 | 10,710 (0%) | 0% | 0.4 | 601 | Common Stock |
| Acorda Therapeutics Inc | Lauren M. Sabella | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.38 per share. | 03 Sep 2021 | 1,511 | 12,221 (0%) | 0% | 4.4 | 6,618 | Common Stock |
| Acorda Therapeutics Inc | Lauren M. Sabella | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 11,125 | 13,732 (0%) | 0% | 0 | Common Stock | |
| Acorda Therapeutics Inc | Lauren M. Sabella | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Sep 2020 | 3,015 | 15,639 (0%) | 0% | 0 | Common Stock |